AVXL - ANAVEX LIFE SCIENCES CORP.

QQQ $ 597.18 $ 0.00 (0 %)

DIA $ 459.15 $ 0.00 (0 %)

SPY $ 658.96 $ 0.00 (0 %)

TLT $ 91.23 $ 0.00 (0 %)

GLD $ 397.77 $ 0.00 (0 %)

Previous Close

$ 9.01

Open

$ 9.00

Bid

$ 8.83 x 71

Ask

$ 9.43 x 14

Day's Range

-- - --

52 Week Range

$ 5.22 - $ 14.44

Volume

987,185

Average Volume

Market Cap

773.9M

Beta (5Y Monthly)

$ 1.53

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-12-2025	06-30-2025	10-Q
2	05-13-2025	03-31-2025	10-Q
3	02-12-2025	12-31-2024	10-Q
4	12-23-2024	09-30-2024	10-K
5	08-06-2024	06-30-2024	10-Q
6	05-09-2024	03-31-2024	10-Q
7	02-07-2024	12-31-2023	10-Q
8	11-27-2023	09-30-2023	10-K
9	08-08-2023	06-30-2023	10-Q
10	05-09-2023	03-31-2023	10-Q
11	02-07-2023	12-31-2022	10-Q
12	11-28-2022	09-30-2022	10-K
13	08-09-2022	06-30-2022	10-Q
14	05-10-2022	03-31-2022	10-Q
15	02-09-2022	12-31-2021	10-Q
16	11-24-2021	09-30-2021	10-K
17	08-12-2021	06-30-2021	10-Q
18	05-13-2021	03-31-2021	10-Q
19	02-16-2021	12-31-2020	10-Q
20	12-28-2020	09-30-2020	10-K
21	08-06-2020	06-30-2020	10-Q
22	05-07-2020	03-31-2020	10-Q
23	02-06-2020	12-31-2019	10-Q
24	12-16-2019	09-30-2019	10-K
25	08-07-2019	06-30-2019	10-Q
26	05-09-2019	03-31-2019	10-Q
27	02-07-2019	12-31-2018	10-Q
28	12-12-2018	09-30-2018	10-K
29	08-09-2018	06-30-2018	10-Q
30	05-10-2018	03-31-2018	10-Q
31	02-07-2018	12-31-2017	10-Q
32	12-11-2017	09-30-2017	10-K
33	08-07-2017	06-30-2017	10-Q
34	05-10-2017	03-31-2017	10-Q
35	02-07-2017	12-31-2016	10-Q
36	12-14-2016	09-30-2016	10-K
37	08-11-2016	06-30-2016	10-Q
38	05-11-2016	03-31-2016	10-Q
39	02-08-2016	12-31-2015	10-Q
40	12-29-2015	09-30-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Anavex Highlights Oral Blarcamesine's Pati...
10/10/2025 11:31:42

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical compan...

HC Wainwright & Co. Reiterates Buy on Anav...
10/07/2025 10:47:39

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

D. Boral Capital Maintains Buy on Anavex L...
10/02/2025 14:37:19

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Announces Development...
10/02/2025 11:37:18

ANAVEX3-71-002 trial achieved its primary endpoint demonstrating safety and tolerability in both male and female adultsOral ANA...

Anavex Schizophrenia Drug Shows Safety Res...
10/02/2025 11:32:24

Anavex Life Sciences Corp. ("Anavex" or the "Company") (NASDAQ:AVXL), a clinical-stage biopharmaceutical compan...

D. Boral Capital Maintains Buy on Anavex L...
10/01/2025 11:27:26

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Announces Publication...
09/30/2025 12:31:28

HC Wainwright & Co. Reiterates Buy on Anav...
09/10/2025 16:45:29

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

D. Boral Capital Maintains Buy on Anavex L...
09/10/2025 11:31:09

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Highlights New Clinic...
09/09/2025 11:36:57

New clinical Precision Medicine population 48-week data demonstrates unprecedented cognitive stabilization in early Alzheimer&#...

D. Boral Capital Maintains Buy on Anavex L...
08/27/2025 12:08:08

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Publishes iScience Study Confirming...
08/26/2025 11:41:34

HC Wainwright & Co. Reiterates Buy on Anav...
08/22/2025 10:43:22

HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $4...

anavex-life-pre-treatment-prevented-cognitive-impairment-in-animal-model-of-alzheimers-disease-new-publication-shows

Anavex Life Pre-Treatment Prevented Cognit...
08/20/2025 11:31:07

Anavex published data showing blarcamesine prevented amyloid-related brain damage in mice, supporting SIGMAR1 as a target for A...

Anavex Life Sciences Peer- Reviewed Public...
08/20/2025 11:29:55

Anavex Life Sciences Says 'This study show...
08/20/2025 11:29:48

D. Boral Capital Maintains Buy on Anavex L...
08/13/2025 16:07:05

D. Boral Capital analyst Jason Kolbert maintains Anavex Life Sciences (NASDAQ:AVXL) with a Buy and maintains $46 price target.

Anavex Life Sciences Q3 EPS $(0.16) Misses...
08/12/2025 11:30:39

Anavex Life Sciences (NASDAQ:AVXL) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate o...

Earnings Scheduled For August 12, 2025
08/12/2025 08:32:28

What to Expect from Anavex Life Sciences's...
08/11/2025 15:03:54